Indivior (INDV.L)

Quick facts

Marketed products

• Subutex · Pain · revenue 800
  Buprenorphine is a partial agonist at mu-opioid receptors and antagonist at kappa-opioid receptors.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Indivior portfolio CI brief
• Indivior pipeline updates RSS